This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (14) Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Soar, K. Articles by Parrott, A. C. Search for Related Content PubMed PubMed Citation Articles by Soar, K. Articles by Parrott, A. C. Social Bookmarking                         What's this?

Problematic versus non-problematic ecstasy/MDMA use: the influence of drug usage patterns and pre-existing psychiatric factors

J. J. D. Turner

School of Psychology, University of East London, London, UK.

A. C. Parrott

Department of Psychology, University of Wales Swansea, Swansea, UK.

Recreational ecstasy (3,4-methylenedioxymethamphetamine; MDMA) use has been increasingly associated with a number of psychiatric symptoms and psychological problems. However, previous studies assessing possible psychopathological effects have not identified whether users consider their ecstasy use ‘problematic’ or not. In addition, research has generally failed to address the potential role of premorbid psychiatric status. This study aimed to assess whether premorbid psychiatric history and/or patterns of ecstasy use would be associated with the degree of selfreported problems attributable to ecstasy. Problematic ecstasy users (n 53) who had reported problems attributable to their ecstasy use were compared with non-problematic ecstasy users (n 62), polydrug controls (n 62) and illegal drug-naive controls (n 111) on a recreational drug use questionnaire; a questionnaire, which ascertained personal and family psychiatric histories, and the Brief Symptom Inventory (BSI). Problematic ecstasy users exhibited significantly higher scores on a number of dimensions of the BSI compared to illegal drugnaive and/or polydrug controls. Problematic ecstasy users also exhibited significantly elevated scores on somatization, depression, anxiety and negative psychobiology compared to non-problematic ecstasy users. BSI scores for the non-problematic ecstasy users did not differ from polydrug or illegal drug-naive controls. Problematic ecstasy users reported significantly higher levels of ecstasy use, including lifetime consumption, average dosage and binge consumption compared to non-problematic ecstasy users. Additionally, a greater number of problematic ecstasy users reported personal and family psychiatric histories compared to controls and non-problematic ecstasy users. This study demonstrates two distinct ecstasy using groups: non-problematic ecstasy users who are not showing signs of psychopathology and problematic ecstasy users who are showing evidence of a range of symptoms. This data therefore partially supports the link between ecstasy dosage and negative psychological sequalae, but highlights the importance of the need to consider ecstasy-related attributions, pre-existing mental health status and vulnerability.

Key Words: problematic ecstasy use • psychopathology • MDMA • premorbid psychiatric history

Journal of Psychopharmacology, Vol. 20, No. 3, 417-424 (2006)
DOI: 10.1177/0269881106063274


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				L. L. Weyandt, G. Janusis, K. G. Wilson, G. Verdi, G. Paquin, J. Lopes, M. Varejao, and C. Dussault Nonmedical Prescription Stimulant Use Among a Sample of College Students: Relationship With Psychological Variables J Atten Disord, November 1, 2009; 13(3): 284 - 296. [Abstract] [PDF]

				K Soar, A Parrott, and J Turner Attributions for psychobiological changes in ecstasy/MDMA and other polydrug users J Psychopharmacol, September 1, 2009; 23(7): 745 - 758. [Abstract] [PDF]

				M. G. Vaughn, J. M. Wallace Jr., L. E. Davis, G. T. Fernandes, and M. O. Howard Variations in Mental Health Problems, Substance Use, and Delinquency Between African American and Caucasian Juvenile Offenders: Implications for Reentry Services Int J Offender Ther Comp Criminol, June 1, 2008; 52(3): 311 - 329. [Abstract] [PDF]

				D. Hasin and H. Katz Somatoform and Substance Use Disorders Psychosom Med, November 1, 2007; 69(9): 870 - 875. [Abstract] [Full Text] [PDF]

				B. Sessa Is there a case for MDMA-assisted psychotherapy in the UK? J Psychopharmacol, March 1, 2007; 21(2): 220 - 224. [Abstract] [PDF]